CYP1A1 and interstitial lung disease: Hydroxyaniline metabolites produced by CYP1A1 can be oxidized to reactive quinone-imine derivatives that form adducts with nucleophilic groups of macromolecules or GSH and may be related to clinically relevant hepatotoxicity or interstitial lung disease [8].